Do you want to read an article? Please log in or register.
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Multiple Sclerosis
Related content
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
RECOMMENDED
Stroke
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Stroke.
Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, Calleja P, Ostos F, González-Ortega G, Fuentes B, Alonso de Leciñana M, Díez-Tejedor E, García-Madrona S, Masjuan J, DeFelipe A, Turc G, Gonçalves B, Domigo V, Dan GA, Vezeteu R, Christensen H, Christensen LM, Meden P, Hajdarevic L, Rodriguez-Lopez A, Díaz-Otero F, García-Pastor A, Gil-Nuñez A, Maslias E, Strambo D, Werring DJ, Chandratheva A, Benjamin L, Simister R, Perry R, Beyrouti R, Jabbour P, Sweid A, Tjoumakaris S, Cuadrado-Godia E, Campello AR, Roquer J, Moreira T, Mazya MV, Bandini F, Matz K, Iversen HK, González-Duarte A, Tiu C, Ferrari J, Vosko MR, Salzer HJF, Lamprecht B, Dünser MW, Cereda CW, Quintero ÁBC, Korompoki E, Soriano-Navarro E, Soto-Ramírez LE, Castañeda-Méndez PF, Bay-Sansores D, Arauz A, Cano-Nigenda V, Kristoffersen ES, Tiainen M, Strbian D, Putaala J, Lip GYH
doi: 10.1161/STROKEAHA.120.031208.
Stroke
Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic
Stroke.
Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK
doi: 10.1161/STROKEAHA.120.029838.
Multiple Sclerosis
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Mult Scler Relat Disord.
Foerch C, Friedauer L, Bauer B, Wolf T, Adam EH
doi: 10.1016/j.msard.2020.102180.
Migraine and Headache
Headaches Associated with Personal Protective Equipment - A Cross-sectional Study Amongst Frontline Healthcare Workers During COVID-19 (HAPPE Study)
Headache.
Jy Ong J, Bharatendu C, Goh Y, Zy Tang J, Wx Sooi K, Lin Tan Y, Yq Tan B, Teoh HL, Ting Ong S, Allen DM, Sharma VK
doi: 10.1111/head.13811.
Further Publications Neurology
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
Front Oncol
Gatson NTN, Barnholtz-Sloan J, Drappatz J, Henriksson R, Hottinger AF, Hinoul P, Kruchko C, Puduvalli VK, Tran DD, Wong ET, Glas M
doi: 10.3389/fonc.2021.679702
Stroke
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke
Stroke
Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, Martínez-Domeño A, Prats-Sánchez L, Guasch-Jiménez M, Cardona P, Núñez-Guillén A, Requena M, Rubiera M, Olivé M, Bustamante A, Gomis M, Amaro S, Llull L, Ustrell X, Castilho de Oliveira G, Seró L, Gomez-Choco M, Mena L, Serena J, Bashir Viturro S, Purroy F, Vicente M, Rodríguez-Campello A, Ois A, Catena E, Carmen Garcia-Carreira M, Barrachina O, Palomeras E, Krupinski J, Almeria M, Zaragoza J, Esteve P, Cocho D, Moreira A, van Eendenburg C, Emilio Codas J, Pérez de la Ossa N, Salvat M, Camps-Renom P
doi: 10.1161/STROKEAHA.121.034883
Further Publications NeurologyFurther Publications Psychiatry
Neurological associations of COVID-19
Lancet Neurol.
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T
doi: 10.
Multiple Sclerosis
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
Mult Scler
Georgieva ZG, Dӧffinger R, Kumararatne D, Coles AJ, McCarthy C
doi: 10.1177/13524585211046786